The Rogosin Institute is an independent, not-for-profit treatment and research center with facilities throughout New York City that treat patients with kidney disease, including dialysis and kidney transplantation; lipid disorders; and hypertension.

During the past decade, Weill Cornell Medical Center / The Rogosin Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Weill Cornell Medical Center / The Rogosin Institute" #1 collaborator was "Vital Systems Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Weill Cornell Medical Center / The Rogosin Institute" are "Colorectal Cancer Metastatic" (1 trials), "Colorectal Cancers" (1 trials), "Pancreatic Adenocarcinoma Metastatic" (1 trials) and "Pancreatic Adenocarcinoma Non-resectable" (1 trials). Many other conditions were trialed in "Weill Cornell Medical Center / The Rogosin Institute" in a lesser frequency.

Most popular intervention types in "Weill Cornell Medical Center / The Rogosin Institute" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "RENCA macrobeads" (2 trials). Other intervention names were less common.

The vast majority of trials in "Weill Cornell Medical Center / The Rogosin Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Weill Cornell Medical Center / The Rogosin Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Weill Cornell Medical Center / The Rogosin Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Weill Cornell Medical Center / The Rogosin Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".